Generalized Anxiety Disorder

8 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Anxiety Disorders, Mental Disorders

Treatments and conditions

Generalized Anxiety Disorder
Treatment and conditionWhere it standsTrials
App AURORA (Digital Therapy) + conventional treatment for generalized anxiety disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Crisugabalin for generalized anxiety disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ITI-1284 10 mg for generalized anxiety disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ITI-1284 20 mg for generalized anxiety disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lysergide d-tartrate for generalized anxiety disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Mindfulness-Based Stress Reduction for generalized anxiety disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin for generalized anxiety disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Venlafaxine for generalized anxiety disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.